Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers
Top Cited Papers
- 27 October 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 12 (12), 731-742
- https://doi.org/10.1038/nrrheum.2016.175
Abstract
The treatment and outcomes of patients with rheumatoid arthritis (RA) have been transformed over the past two decades. Low disease activity and remission are now frequently achieved, and this success is largely the result of the evolution of treatment paradigms and the introduction of new therapeutic agents. Despite the rapid pace of change, the most commonly used drug in RA remains methotrexate, which is considered the anchor drug for this condition. In this Review, we describe the known pharmacokinetic properties and putative mechanisms of action of methotrexate. Consideration of the pharmacodynamic perspective could inform the development of biomarkers of responsiveness to methotrexate, enabling therapy to be targeted to specific groups of patients. Such biomarkers could revolutionize the management of RA.Keywords
This publication has 157 references indexed in Scilit:
- Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA studyAnnals Of The Rheumatic Diseases, 2012
- T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupusCellular Immunology, 2011
- Increased sensitivity to apoptosis induced by methotrexate is mediated by JNKArthritis & Rheumatism, 2011
- Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiencyFree Radical Biology & Medicine, 2011
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An UpdatePharmacological Reviews, 2011
- Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesisBiochemical Pharmacology, 2009
- Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature researchAnnals Of The Rheumatic Diseases, 2008
- Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literatureAnnals Of The Rheumatic Diseases, 2008
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent‐onset rheumatoid arthritisArthritis & Rheumatism, 2007